Skip to content

An observational study to gauge the effect of preeclampsia on the immune system of the baby

EFFECT OF PREECLAMPSIA INDUCED PRENATAL HYPOXIA ON INFANT T REGULATORY CELL RELATED GENE EXPRESSION - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/081803
Enrollment
48
Registered
2025-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O141- Severe pre-eclampsia

Interventions

Control Intervention1: NIL: NIL

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria for mothers: All consenting primiparous mothers, 18-40yrs old diagnosed with preeclampsia according to ISSHP guidelines 2021, undergoing elective caesarean section between 37 weeks to 40 weeks of gestation in hospital will be included in the study. Inclusion Criteria for infant : All infants born to consenting primiparous mothers, 18-40yrs old diagnosed with preeclampsia according to ISSHP guidelines 2021, undergoing elective caesarean section between 37 weeks to 40 weeks of gestation in hospital will be included in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for mother: Mothers not willing to give consent. Deliveries of unknown gestational age. Mothers with pre-existing chronic hypertension, chronic diabetes and other chronic illnesses. Exclusion Criteria for infant : Infants with obvious congenital anomalies. Infants suffering from meconium aspiration syndrome Infants with intrauterine growth restriction (IUGR) not related to pregnancy induced hypertension (PIH).

Design outcomes

Primary

MeasureTime frame
To determine the effect of preeclampsia induced prenatal hypoxia on T Regulatory cell-related gene expression in the infant cord blood. Timepoint: Immediately at birth

Secondary

MeasureTime frame
To find a correlation between PO2, PCO2, lactate levels, bicarbonate levels & FOXP3, CTLA4 & GATA3 gene expression.Timepoint: Immediately at birth

Countries

India

Contacts

Public ContactMallanagouda M Patil

Shri B M Patil Medical College Hospital and Research Centre

mm.patil@bldedu.ac.in9900291825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026